- Home
- CLRB vs NCRA Comparison
CLRB vs NCRA Comparison
Compare CLRB & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- NCRA
- Stock Information
- Founded
- CLRB 2002
- NCRA 2002
- Country
- CLRB United States
- NCRA Taiwan
- Employees
- CLRB N/A
- NCRA N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- CLRB Health Care
- NCRA Consumer Staples
- Exchange
- CLRB Nasdaq
- NCRA Nasdaq
- Market Cap
- CLRB 14.2M
- NCRA 15.1M
- IPO Year
- CLRB N/A
- NCRA N/A
- Fundamental
- Price
- CLRB $5.49
- NCRA $1.48
- Analyst Decision
- CLRB Hold
- NCRA
- Analyst Count
- CLRB 2
- NCRA 0
- Target Price
- CLRB N/A
- NCRA N/A
- AVG Volume (30 Days)
- CLRB 89.6K
- NCRA 18.8K
- Earning Date
- CLRB 11-17-2025
- NCRA 11-13-2025
- Dividend Yield
- CLRB N/A
- NCRA N/A
- EPS Growth
- CLRB N/A
- NCRA N/A
- EPS
- CLRB N/A
- NCRA N/A
- Revenue
- CLRB N/A
- NCRA $13,865,984.00
- Revenue This Year
- CLRB N/A
- NCRA N/A
- Revenue Next Year
- CLRB N/A
- NCRA N/A
- P/E Ratio
- CLRB N/A
- NCRA N/A
- Revenue Growth
- CLRB N/A
- NCRA N/A
- 52 Week Low
- CLRB $4.11
- NCRA $0.70
- 52 Week High
- CLRB $67.50
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- CLRB 60.03
- NCRA 46.32
- Support Level
- CLRB $5.05
- NCRA $1.43
- Resistance Level
- CLRB $5.34
- NCRA $1.60
- Average True Range (ATR)
- CLRB 0.34
- NCRA 0.10
- MACD
- CLRB 0.07
- NCRA -0.01
- Stochastic Oscillator
- CLRB 98.15
- NCRA 40.00
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.